Registered entities
RESPICARDIA INC
Reg. No. 205243386United States
Innovation
9 patent families (8 granted) — focus: Human necessities; filing pace slowing. Cited 2,227 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 3 |
Social engagement
Social engagement: 4.8K social following, 8 posts in the last 12 months — around the industry typical range.
Investor mix
11 investors on record; lead investors include Sorin Group, ZOLL AEDs, Polaris Partners, Versant Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 64% |
| Private equity | 1 | 9% |
| Other / undisclosed | 3 | 27% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
13 May 2026 · Director of Sales Training
Based on job postings tracked across public sources.
Recent activity
19 Jun 2026
Event
Free educational webinar on CSA, Transvenous Phrenic Nerve Stimulation (TPNS) and clinical evidence supporting the remed® System
16 Jun 2026
Event
SLEEP 2026
11 Jun 2026
Event
SLEEP2026